|
Evrofarma SA is #46 in rating Stock price grown in a month in Greece. Evrofarma SA is #73 in rating Stock price grown in a year in Greece. Evrofarma SA is #78 in rating Stock price grown in 3 years in Greece. Evrofarma SA is #85 in rating Capitalization in Greece. Evrofarma SA is #87 in rating Stock price grown in 3 months in Greece. Evrofarma SA is #101 in rating Stock price grown in a week in Greece. Evrofarma SA is #46 in rating Stock price grown in a month on ATH. Evrofarma SA is #73 in rating Stock price grown in a year on ATH. Evrofarma SA is #78 in rating Stock price grown in 3 years on ATH. Evrofarma SA is #85 in rating Capitalization on ATH. Evrofarma SA is #87 in rating Stock price grown in 3 months on ATH. Evrofarma SA is #101 in rating Stock price grown in a week on ATH.
Evrofarma SA ratings on the stock exchange are a set of ratings for a particular stock exchange.Rating Evrofarma SA company capitalization is a rating based on the sum of the value of all company shares. Companies with higher shares have higher ratings and are more expensive. It is not difficult to guess that the top of the capitalization rating indicates that this is one of the most expensive companies.
Evrofarma SA earnings per share rating is determined in each financial period. Earnings per share - an indicator calculated by the formula: all the company's profit for the reporting period by the number of shares in the company. The “earnings per share” rating is higher if the company's earnings per share are greater.
Rating Evrofarma SA net income - a list of companies collected by the amount of total income. Net income is calculated as the total revenue of the company, not taking into account the quantity and value of its shares. The top ranking of "Net income of the company" is usually headed by the largest and most profitable companies.
|
